PACIFIC BIOSCIENCES OF CALIFORNIA, INC.(PACB)— Stock Profile, AI Score & Financials

Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores PACB at 17.1/100 on a 32-signal composite quality model, placing it at rank #2,829 of 2,960 stocks — the bottom half of the AI-ranked universe. Areas of concern include earnings quality (5.4) and free cash flow (7.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 6.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reports quarterly revenue of $39.0M, net income of $-44.7M, free cash flow of $-37.1M. Top institutional holders of PACB by reported 13-F value include BlackRock, ARK Investment Management, SOFTBANK GROUP, based on the most recent SEC filings. PACB trades on the Nasdaq exchange and files with the SEC under CIK 1299130. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PACB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. directly from SEC EDGAR.